HUNTINGTON NATIONAL BANK - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48,511
-1.5%
6,852
-2.0%
0.00%
Q2 2023$49,238
-11.7%
6,994
+4.7%
0.00%
-100.0%
Q1 2023$55,736
-12.4%
6,683
+20.6%
0.00%0.0%
Q4 2022$63,634
-9.1%
5,543
-0.7%
0.00%0.0%
Q3 2022$70,000
+45.8%
5,582
+24.0%
0.00%0.0%
Q2 2022$48,000
-34.2%
4,5010.0%0.00%0.0%
Q1 2022$73,000
+17.7%
4,5010.0%0.00%0.0%
Q4 2021$62,000
-4.6%
4,5010.0%0.00%0.0%
Q3 2021$65,000
-8.5%
4,5010.0%0.00%0.0%
Q2 2021$71,000
+54.3%
4,5010.0%0.00%0.0%
Q1 2021$46,000
+35.3%
4,5010.0%0.00%
Q4 2020$34,000
+126.7%
4,5010.0%0.00%
Q3 2020$15,000
-28.6%
4,5010.0%0.00%
Q2 2020$21,000
+133.3%
4,5010.0%0.00%
Q1 2020$9,000
-43.8%
4,5010.0%0.00%
Q4 2019$16,000
+23.1%
4,5010.0%0.00%
Q3 2019$13,000
-23.5%
4,5010.0%0.00%
Q2 2019$17,000
-54.1%
4,501
+0.0%
0.00%
-100.0%
Q1 2019$37,000
+2.8%
4,500
-0.0%
0.00%0.0%
Q4 2018$36,000
+5.9%
4,5010.0%0.00%0.0%
Q3 2018$34,000
+30.8%
4,501
+0.0%
0.00%
Q2 2018$26,0004,5000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders